Terminated NA INTERVENTIONAL 4-arm NCT01534676

Effects of Transfusion of Older Stored Red Cells

Harmful Effects of Transfusion of Older Stored Red Cells: Iron and Inflammation

Sponsor: Columbia University

Conditions Sickle Cell Disease Thalassemia

Interventions Blood Chelation therapy Transfusion

Updated 6 times since 2017 Last updated: Aug 11, 2016 Started: Feb 29, 2012 Primary completion: Mar 31, 2013 Completion: Mar 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Difficulty recruiting donors and recipients, looking for alternative sites

Other terminated trials from Columbia University

See all terminations from Columbia University

Other Sickle Cell Disease trials with similar outcome

Browse all Sickle Cell Disease trials

Listed as NCT01534676, this NA trial focuses on Sickle Cell Disease and Thalassemia and remains terminated or withdrawn. Sponsored by Columbia University, it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Feb 2017 — Jun 2018 [monthly]

Terminated NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Terminated NA

First recorded

Feb 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Columbia University
National Heart, Lung, and Blood Institute (NHLBI)

Data source: Columbia University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States